ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental pill KPT-9274 tested in Tough-to-Treat leukemia
Disease control CompletedThis early-phase study tested an oral drug called KPT-9274 in 16 adults with acute myeloid leukemia that had come back or not responded to prior treatments. The main goal was to find the safest dose and see how well patients tolerated the drug. The study is complete, but results …
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New targeted therapy shows promise for Hard-to-Treat leukemia
Disease control CompletedThis study tested a drug called GO-203-2C that targets cancer cells while leaving healthy cells alone. It was given to 33 adults with acute myeloid leukemia (AML) that had come back or not responded to standard treatment. The goal was to find the safest dose and see if adding ano…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC